Macedonia’s First Licensed Cannabis Cultivation Facility Scales Lighting Solutions with Focus on Controlling Consistency for Business Growth and Medicinal Product Quality
(GOTHENBURG, Sweden / SAN FRANCISCO, CA, June 8, 2017) – Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announced a second order from Mak North America of Heliospectra LED lighting solutions as the company opens the first licensed medicinal cannabis cultivation facility in the Republic of Macedonia. The order value is USD 184,560 (1,5 million SEK). Delivery will take place at the beginning of Q3 and be visible in the accounts in Q2 and Q3.
“As Mak North scales operations in Macedonia, lighting becomes a critical factor to maintain superior plant health, create accurate business and yield forecasts and deliver pharmaceutical grade cannabis to domestic and export markets,” said Kris Swaffer, CEO of Mak North America. “The Heliospectra LED solutions and the ability to truly control consistency and accelerate the harvest of medicinal marijuana are core components for sustainable business success.”
The 2,415 square meters Mak North facility (26,000-square foot) integrates Heliospectra’s E60 series 600 watt LEDs with a vertical tier growing system to distribute an optimized, high intensity light spectrum across the complete cannabis growth cycle and in multiple rooms from vegetative to flowering.
“At Heliospectra, we focus on growers’ business models and profitability. In close collaboration with our customers we develop solutions that help them not only reach their goals but to do it faster, more efficiently and in an environmentally and economically sustainable way,” said Ali Ahmadian, CEO of Heliospectra. “Mak North will be able to standardize the quality and medicinal profiles of the cannabis plant while at the same time speeding production cycles by up to 10 days. By controlling consistency, Mak North is able to supply their customers with high-quality products and create predictable and repeatable business results.”
About Mak North America
Headquartered in Dallas, Texas, Mak North America has established a thriving export business providing sunflower oils and extracts to companies worldwide. If you would like to learn more about Mak North America and the Macedonia facility, please contact CEO Kris Swaffer at [email protected].
Join the Heliospectra conversation:
Read more at www.heliospectra.com/blog
Follow @Heliospectra on Twitter
Like Heliospectra on Facebook at facebook.com/heliospectra
Join the #justsaynotohps community on www.instagram.com/justsaynotohps/
Ali Ahmadian, CEO of Heliospectra | +46 (0)72 203 63 44 | [email protected]
Redeye is Heliospectra’s Certified Advisor for Nasdaq First North - www.redeye.se
About Heliospectra AB
Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO) is the industry’s most proven intelligent lighting technology for greenhouse and controlled plant growth environments. With the vision to make commercial crop production more connected and resource-efficient, growers and commercial producers across six continents use Heliospectra’s holistic and flexible solutions to consistently increase yields while producing crops that achieve quality appearance, superior nutritional or medicinal value and longer shelf life, harvest after harvest. Founded in 2006 and winner of multiple international awards and recognitions, Heliospectra has raised more than $32 million in capital to date. As a publicly traded company, the majority ownership remains with some of Heliospectra's earliest investors Weland Steel, Swedish Industrial Fund and Midroc New Technology. For more information, please visit https://www.heliospectra.com.
The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.
This information is information that Heliospectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14:00 CEST / 7 AM CDT on June 8, 2017.